For the past 20 years, biotechnology medicines have aided those suffering from chronic conditions, including cancer, diabetes, and auto-immune diseases such as multiple sclerosis and rheumatoid arthritis. Graham Reynolds at West Pharmaceutical Services looks at the success of biologics, which offer patients better long- term outcomes and fewer side-effects than traditional, chemical- based therapies, and how this has led to a rise in biological drugs over the past several years.

[prettyfilelink src=”” type=”pdf”]Collaborative Development Finding Solutions for the Packaging Challenges of Modern Injectable Biologics[/prettyfilelink]

Comments are closed.

%d bloggers like this: